IMPROVE bleeding risk score: Difference between revisions
Jump to navigation
Jump to search
(10 intermediate revisions by the same user not shown) | |||
Line 7: | Line 7: | ||
==IMPROVE Bleeding Risk Score== | ==IMPROVE Bleeding Risk Score== | ||
The IMPROVE bleeding risk score estimates the risk of bleeding among acutely ill hospitalized patients.<ref name="pmid20453069">{{cite journal| author=Decousus H, Tapson VF, Bergmann JF, Chong BH, Froehlich JB, Kakkar AK et al.| title=Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. | journal=Chest | year= 2011 | volume= 139 | issue= 1 | pages= 69-79 | pmid=20453069 | doi=10.1378/chest.09-3081 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20453069 }} </ref> | The IMPROVE bleeding risk score estimates the risk of bleeding among acutely ill hospitalized patients.<ref name="pmid20453069">{{cite journal| author=Decousus H, Tapson VF, Bergmann JF, Chong BH, Froehlich JB, Kakkar AK et al.| title=Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. | journal=Chest | year= 2011 | volume= 139 | issue= 1 | pages= 69-79 | pmid=20453069 | doi=10.1378/chest.09-3081 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20453069 }} </ref><ref name="pmid26867833">{{cite journal |vauthors=Hostler DC, Marx ES, Moores LK, Petteys SK, Hostler JM, Mitchell JD, Holley PR, Collen JF, Foster BE, Holley AB |title=Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk Score |journal=Chest |volume=149 |issue=2 |pages=372–9 |date=February 2016 |pmid=26867833 |doi=10.1378/chest.14-2842 |url=}}</ref> | ||
==IMPROVE Bleeding Risk Score Calculator== | ==IMPROVE Bleeding Risk Score Calculator== | ||
{| | {| class="wikitable" | ||
|- | |- | ||
! colspan="2" |Variable | |||
! Score | |||
|- | |- | ||
| | | rowspan="3" |Age | ||
| ≥ 85 years | |||
| 3.5 | |||
|- | |- | ||
| | |40-84 years | ||
|1.5 | |||
|- | |- | ||
| | |&lt; 40 | ||
|0 | |||
|- | |- | ||
| | | rowspan="2" |Gender | ||
|Male | |||
|1 | |||
|- | |- | ||
| | |Female | ||
|0 | |||
|- | |- | ||
| | | rowspan="3" |Kidney function | ||
|Normal kidney function (GFR ≥ 60 mL/min/m<sup>2</sup>) | |||
|0 | |||
|- | |- | ||
| | |[[Kidney failure|Moderate kidney failure]] ([[GFR]] 30-59 mL/min/m<sup>2</sup>) | ||
|1 | |||
|- | |- | ||
| | |[[Kidney failure|Severe kidney failure]] ([[GFR]] &lt; 30 mL/min/m<sup>2</sup>) | ||
|2.5 | |||
|- | |- | ||
| | | rowspan="2" |Liver function | ||
|Normal liver function (INR ≤ 1.5) | |||
|0 | |||
|- | |- | ||
| | |[[Liver failure]] ([[INR]] &gt; 1.5) | ||
|2.5 | |||
|- | |- | ||
| | | rowspan="2" |Platelet | ||
|≥ 50x10<sup>9</sup>/L | |||
|0 | |||
|- | |- | ||
| | |&lt; 50x10<sup>9</sup>/L | ||
|4 | |||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" | | | colspan="2" |Admission to [[ICU]] or [[CCU]] | ||
|2.5 | |||
|- | |||
| colspan="2" |[[Central venous catheter]] | |||
|2 | |||
|- | |||
| colspan="2" |Active [[gastric ulcer|gastric]] or [[duodenal ulcer]] | |||
|4.5 | |||
|- | |||
| colspan="2" |Prior [[bleeding]] within the last 3 months|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |4 | |||
|- | |||
| colspan="2" |Rheumatic disease|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2 | |||
|- | |||
| colspan="2" |Active [[malignancy]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2 | |||
|} | |} | ||
==Interpretation== | ==Interpretation== | ||
Latest revision as of 06:30, 10 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
The IMPROVE bleeding risk score estimates the risk of bleeding among acutely ill hospitalized patients.
IMPROVE Bleeding Risk Score
The IMPROVE bleeding risk score estimates the risk of bleeding among acutely ill hospitalized patients.[1][2]
IMPROVE Bleeding Risk Score Calculator
Variable | Score | |
---|---|---|
Age | ≥ 85 years | 3.5 |
40-84 years | 1.5 | |
< 40 | 0 | |
Gender | Male | 1 |
Female | 0 | |
Kidney function | Normal kidney function (GFR ≥ 60 mL/min/m2) | 0 |
Moderate kidney failure (GFR 30-59 mL/min/m2) | 1 | |
Severe kidney failure (GFR < 30 mL/min/m2) | 2.5 | |
Liver function | Normal liver function (INR ≤ 1.5) | 0 |
Liver failure (INR > 1.5) | 2.5 | |
Platelet | ≥ 50x109/L | 0 |
< 50x109/L | 4 | |
Admission to ICU or CCU | 2.5 | |
Central venous catheter | 2 | |
Active gastric or duodenal ulcer | 4.5 | |
Prior bleeding within the last 3 months | 4 | |
Rheumatic disease | 2 | |
Active malignancy | 2 |
Interpretation
The IMPROVE risk score for bleeding can be interpreted as such:[1]
- Score ≥7: Increased risk of bleeding
- Score <7: Not increased risk of bleeding
See also
References
- ↑ 1.0 1.1 Decousus H, Tapson VF, Bergmann JF, Chong BH, Froehlich JB, Kakkar AK; et al. (2011). "Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators". Chest. 139 (1): 69–79. doi:10.1378/chest.09-3081. PMID 20453069.
- ↑ Hostler DC, Marx ES, Moores LK, Petteys SK, Hostler JM, Mitchell JD, Holley PR, Collen JF, Foster BE, Holley AB (February 2016). "Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk Score". Chest. 149 (2): 372–9. doi:10.1378/chest.14-2842. PMID 26867833.